Third Major COVID-19 Vaccine Up To 90% Effective, Trial Results Show

AstraZeneca and Oxford University on Monday said their jointly created COVID-19 vaccine has proven to be up to 90% effective and easier to distribute than another potential vaccine, which must be kept at sub-zero temperatures.

“These findings show that we have an effective vaccine that will save many lives,” said Oxford University professor Andrew Pollard, who served as the lead investigator for the drug’s trials. “Because the vaccine can be stored at fridge temperatures, it can be distributed around the world using the normal immunization distribution system. And so our goal … to make sure that we have a vaccine that was accessible everywhere, I think we’ve actually managed to do that.”